| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Prevention |
1 Department of Internal Medicine and 2 Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, Ohio and 3 Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan
Requests for reprints: Gary D. Stoner, Department of Internal Medicine, The Ohio State University College of Medicine, Innovation Centre, 2001 Polaris Parkway, Columbus, OH 43240. Phone: 614-293-3268; Fax: 614-293-5952; E-mail: gary.stoner{at}osumc.edu.
Key Words: berries PEITC gene expression chemoprevention rodent esophagus
Our recent study identified 2,261 dysregulated genes in the esophagi of rats that received a 1-week exposure to the carcinogen N-nitrosomethylbenzylamine (NMBA). We further reported that 1,323 of these genes were positively modulated to near-normal levels of expression in NMBA-treated animals that consumed dietary phenylethyl isothiocyanate (PEITC), a constituent of cruciferous vegetables. Herein, we report our results with companion animals that were fed a diet containing 5% freeze-dried black raspberries (BRB) instead of PEITC. We found that 462 of the 2,261 NMBA-dysregulated genes in rat esophagus were restored to near-normal levels of expression by BRB. Further, we have identified 53 NMBA-dysregulated genes that are positively modulated by both PEITC and BRB. These 53 common genes include genes involved in phase I and II metabolism, oxidative damage, and oncogenes and tumor suppressor genes that regulate apoptosis, cell cycling, and angiogenesis. Because both PEITC and BRB maintain near-normal levels of expression of these 53 genes, their dysregulation during the early phase of NMBA-induced esophageal cancer may be especially important in the genesis of the disease. [Cancer Res 2008;68(15):6460–7]
This article has been cited by other articles:
![]() |
G. D. Stoner Foodstuffs for Preventing Cancer: The Preclinical and Clinical Development of Berries Cancer Prevention Research, March 1, 2009; 2(3): 187 - 194. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |